Immunotherapy of established tumors in mice by intratumoral injection of an adenovirus vector harboring the human IL-2 cDNA: Induction of CD8+ T-cell immunity and NK activity-Reference-Cited by-同舟云学术

Immunotherapy of established tumors in mice by intratumoral injection of an adenovirus vector harboring the human IL-2 cDNA: Induction of CD8+ T-cell immunity and NK activity

Published:2001-05 Issue:5 Volume:8 Page:321-332
ISSN:0929-1903
Container-title:Cancer Gene Therapy
language:en
Short-container-title:Cancer Gene Ther

Author:

Slos Philippe,De Meyer Micael,Leroy Pierre,Rousseau Cedrick,Acres Bruce

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/7700309.pdf

Reference50 articles.

1. Farrar JJ, Benjamin WR, Hilfiker ML, et al . The biochemistry, biology, and the role of interleukin-2 in the induction of cytotoxic T cell and antibody-forming B-cell responses Immunol Rev 1982 63: 129–166

2. Rosenberg SA, Lotze MT . Cancer immunotherapy interleukin-2 and interleukin-2–activated lymphocytes Annu Rev Immunol 1986 4: 681–709

3. Rosenberg SA, Lotze MT, Yang JC, et al . Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients Ann Surg 1989 210: 474–484

4. West WH, Tauer KW, Yanelli JR, et al . Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer N Engl J Med 1987 316: 898–905

5. Parkinson DR, Abrams JS, Wiernik PH, et al . Interleukin-2 therapy in patients with metastatic malignant melanoma: a phase II study J Clin Oncol 1990 8: 1650–1656

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging IL-12-based nanomedicine for cancer therapy;Nano Today;2024-08

2. Interleukin gene delivery for cancer gene therapy: In vitro and in vivo studies;IRAN J BASIC MED SCI;2023

3. Oncolytic ImmunoViroTherapy: A long history of crosstalk between viruses and immune system for cancer treatment;Pharmacology & Therapeutics;2022-08

4. Blockade of transforming growth factor β2 by anti-sense oligonucleotide improves immunotherapeutic potential of IL-2 against melanoma in a humanized mouse model;Cytotherapy;2021-07

5. Localized Interleukin-12 for Cancer Immunotherapy;Frontiers in Immunology;2020-10-15